Stay updated on Durvalumab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab in Cervical Cancer Clinical Trial page.

Latest updates to the Durvalumab in Cervical Cancer Clinical Trial page
- Check4 days agoChange DetectedAdded Tainan, Taiwan, 704 as a study site and removed Tainan City, Taiwan, 704 from the locations. This updates the geographic coverage of trial sites for potential participants.SummaryDifference0.0%

- Check12 days agoChange DetectedAdded Gurgaon, India, 122001 as a study site location and removed Gūrgaon, India, 122001. This reflects updated spelling and site listing in the study's locations.SummaryDifference0.0%

- Check19 days agoChange DetectedEnrollment updated to 770. Primary Completion Date updated to 2022-01-20 and Study Completion Date updated to 2023-07-03 in the Study Details.SummaryDifference0.2%

- Check41 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check49 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check63 days agoChange DetectedVersion updated to v3.0.2 from v3.0.1; the 'Back to Top' link was removed.SummaryDifference0.2%

Stay in the know with updates to Durvalumab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab in Cervical Cancer Clinical Trial page.